Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Filings indexed 304 across all filing types
Latest filing 2022-03-31 Board/Management Inform…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of an outside director (사외이사). This type of corporate disclosure specifically concerns changes in the board of directors, which falls under the 'Board/Management Information' category.
2022-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on financial statements, dividend declarations, and the election of directors and auditors. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details changes in share ownership by major shareholders and their special relations, including specific transaction dates, methods (e.g., open market sales), and collateral agreements. This falls under the 'Major Shareholding Notification' category.
2022-03-25 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific changes in share ownership by individuals and entities related to the company, including dates of change, number of shares, and the relationship to the company. This type of filing is a standard regulatory disclosure regarding insider or major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category as it reports personal share transactions by company-related parties.
2022-03-25 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Yuyu Pharma, covering the fiscal year 2021 (Jan 1, 2021 to Dec 31, 2021). It contains detailed financial data, management discussion, business overview, and corporate governance information. In the context of South Korean regulatory filings (DART), this is the equivalent of a 10-K annual report. FY 2021
2022-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Yuyu Pharma. It provides the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and confirms the receipt of the audit report from the external auditor. While it contains financial data, it is a summary announcement of the audit report filing rather than the full annual report (10-K) or a standalone audit report document. According to the 'Menu vs Meal' rule, this is a notification of the report's availability and submission to the regulatory body (KRX), making it a Report Publication Announcement. FY 2021
2022-03-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.